| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |